Modulation of renal hemodynamics by IGF-1 is absent in spontaneously hypertensive rats

Kidney Int. 1997 Jul;52(1):165-70. doi: 10.1038/ki.1997.316.

Abstract

We recently reported that attenuation of vasoactive agent-induced calcium signal and cell contraction of mesangial cell by insulin-like growth factor 1 (IGF-1), observed in normal mesangial cells, is totally abolished in spontaneously hypertensive rat (SHR) mesangial cells. This phenomenon might be related to the well-known aberrant regulation of SHR glomerular hemodynamics. Since it has been reported that in vivo IGF-1 infusion increases renal plasma flow (RPF) and glomerular filtration rate (GFR), we examined whether the modulation of renal function by IGF-1 is altered in SHR. We performed in vivo renal clearance studies using eight-week-old SHR and control Wistar Kyoto rats (WKY) before and after IGF-1 (5 micrograms/kg) infusion into the left renal artery for 20 minutes. Mean arterial pressure was not affected by IGF-1 in both WKY and SHR. In WKY, IGF-1 increased GFR and RPF, and decreased renal vascular resistance (RVR). However, GFR, RPF, and RVR were not altered by IGF-1 in SHR, while systemic infusion of angiotensin II antagonist, CV-11974, increased GFR and RPF. The present data show that the modulation of renal hemodynamics by IGF-1 is absent in SHR. This might be related the pathophysiology of the development of hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzimidazoles / pharmacology
  • Biphenyl Compounds
  • Blood Glucose / drug effects
  • Glucagon / blood
  • Hemodynamics / drug effects*
  • Hypertension / physiopathology*
  • Injections, Intra-Arterial
  • Insulin / blood
  • Insulin-Like Growth Factor I / analysis
  • Insulin-Like Growth Factor I / pharmacology*
  • Kidney / drug effects
  • Kidney / physiopathology*
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Tetrazoles / pharmacology

Substances

  • Benzimidazoles
  • Biphenyl Compounds
  • Blood Glucose
  • Insulin
  • Tetrazoles
  • Insulin-Like Growth Factor I
  • Glucagon
  • candesartan